Home/South African Medical Journal (SAMJ)/Article Record
Peer-Reviewed Article April 18, 2016

Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: South African Medical Journal (SAMJ)
Publisher: South African Medical Association • South Africa • 0256-9574 • 2078-5135
DOI: https://doi.org/10.7196/samj.2016.v106i5.10710

Abstract

The polymyxin antibiotic colistin is an antibiotic of last resort for the treatment of extensively drug-resistant Gram-negative bacteria, including carbapenemase-producing Enterobacteriaceae. The State of the World's Antibiotics report in 2015 highlighted South Africa (SA)'s increasing incidence of these 'superbugs' (3.2% of Klebsiella pneumoniae reported from SA were carbapenemase producers), and in doing so, underscored SA's increasing reliance on colistin as a last line of defence. Colistin resistance effectively renders such increasingly common infections untreatable.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

83
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.